» Articles » PMID: 38216697

Directional Deep Brain Stimulation in the Management of Parkinson's Disease: Efficacy and Constraints-an Analytical Appraisal

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2024 Jan 12
PMID 38216697
Authors
Affiliations
Soon will be listed here.
Abstract

Deep brain stimulation (DBS) is a widely employed treatment for Parkinson's disease. However, conventional DBS utilizing ring-shaped leads can often result in undesirable side effects by stimulating nearby brain structures, thus limiting its effectiveness. To address this issue, a novel DBS electrode was developed to allow for directional stimulation, avoiding neighboring structures. This literature review aims to analyze the disparities between conventional and directional DBS and discuss the benefits and limitations associated with this innovative electrode design, focusing on the stimulation-induced side effects it can or cannot mitigate. A comprehensive search was conducted in MEDLINE/PubMed, ScienceDirect, and EBSCO databases using the Boolean search criteria: "Deep brain stimulation" AND "Parkinson" AND "Directional." Following the application of inclusion and exclusion criteria, the selected articles were downloaded for full-text reading. Subsequently, the results were organized and analyzed to compose this article. Numerous studies have demonstrated that directional DBS effectively reduces side effects associated with brain stimulation, prevents the stimulation of non-targeted structures, and expands the therapeutic window, among other advantages. However, it has been observed that directional DBS may be more challenging to program and requires higher energy consumption. Furthermore, there is a lack of standardization among different manufacturers of directional DBS electrodes. Various stimulation-induced side effects, including dysarthria, dyskinesia, paresthesias, and symptoms of pyramidal tract activation, have been shown to be mitigated with the use of directional DBS. Moreover, directional electrodes offer a wider therapeutic window and a reduced incidence of undesired effects, requiring the same or lower minimum current for symptom relief compared to conventional DBS. The utilization of directional leads in DBS offers numerous advantages over conventional electrodes without significant drawbacks for patients undergoing directional DBS therapy.

References
1.
Tysnes O, Storstein A . Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017; 124(8):901-905. DOI: 10.1007/s00702-017-1686-y. View

2.
Krauss J, Lipsman N, Aziz T, Boutet A, Brown P, Chang J . Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2020; 17(2):75-87. PMC: 7116699. DOI: 10.1038/s41582-020-00426-z. View

3.
Pollo C, Kaelin-Lang A, Oertel M, Stieglitz L, Taub E, Fuhr P . Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014; 137(Pt 7):2015-26. DOI: 10.1093/brain/awu102. View

4.
Merola A, Romagnolo A, Krishna V, Pallavaram S, Carcieri S, Goetz S . Current Directions in Deep Brain Stimulation for Parkinson's Disease-Directing Current to Maximize Clinical Benefit. Neurol Ther. 2020; 9(1):25-41. PMC: 7229063. DOI: 10.1007/s40120-020-00181-9. View

5.
Contarino M, Bour L, Verhagen R, Lourens M, de Bie R, van den Munckhof P . Directional steering: A novel approach to deep brain stimulation. Neurology. 2014; 83(13):1163-9. DOI: 10.1212/WNL.0000000000000823. View